Density-gradient-free solutions 
for cell isolation

Live webinar

The current restrictions in laboratories worldwide caused by the Covid-19 pandemic have made it more important than ever before to optimize experimental workflows due to social distancing, working in shifts and reduced availability of fresh blood materials. Density-gradient centrifugation is time-consuming, labor-intensive, and the results vary depending on the user. Do you want to skip this process, follow all given Covid-19 regulations and get your experiments done to reach your 2020 goals? Miltenyi Biotec offers a large portfolio of Ficoll®-free options for primary cell isolation directly from human blood materials, including Leukopaks®, buffy coats, LRSCs and whole blood samples.  

Learn how to make your PBMC and immune cell isolations easier, faster and more economical, while improving reproducibility and user safety by automating your cell separation processes.   

There will be time for questions and discussion after the 45 min presentation.


Sessions (choice of two dates)

August 25, 2020
Berlin, Germany (GMT+02:00)  − 7:00 PM CET
San Francisco, CA, USA (GMT-07:00) − 10:00 AM PST
New York, NY, USA (GMT-04:00)  − 1:00 PM EDT

Register here

August 27, 2020
Berlin, Germany (GMT+02:00)  − 10:00 AM CET
London, United Kingdom (GMT+01:00) − 9:00 AM GMT
Singapore, Singapore (GMT+08:00)  − 4:00 PM

Register here


About the presenter

Kristina joined Miltenyi Biotec in 2017 as a Global Product Manager for Cell Separation. In this role, she manages the launch and marketing of reagents and cell separation instruments, focusing on applications in Biotech, Pharma and CROs. Prior to joining Miltenyi, Kristina worked as a Sales Consultant at jobvector, a specialized career board for science and engineering.

Kristina Kremer, Miltenyi Biotec